Works matching IS 03125963 AND DT 2025 AND VI 64 AND IP 3


Results: 12
    2
    3
    4
    5
    6
    7

    Exposure to Rifampicin and its Metabolite 25-Deacetylrifampicin Rapidly Decreases During Tuberculosis Therapy: Pharmacokinetics of Rifampicin and Active Metabolite: S. Goutelle et al.

    Published in:
    Clinical Pharmacokinetics, 2025, v. 64, n. 3, p. 387, doi. 10.1007/s40262-025-01479-3
    By:
    • Goutelle, Sylvain;
    • Bahuaud, Olivier;
    • Genestet, Charlotte;
    • Millet, Aurélien;
    • Parant, François;
    • Dumitrescu, Oana;
    • Ader, Florence;
    • Ader, F.;
    • Bahuaud, O.;
    • Bayaa, R.;
    • Becker, A.;
    • Braun, E.;
    • Chabert, P.;
    • Chauvelot, P.;
    • Chedid, C.;
    • Conrad, A.;
    • Dumitrescu, O.;
    • Ferry, T.;
    • Genestet, C.;
    • Goutelle, S.
    Publication type:
    Article
    8

    Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity: DOAC Concentrations in Patients with Obesity and Atrial Fibrillation: D. Menichelli et al.

    Published in:
    Clinical Pharmacokinetics, 2025, v. 64, n. 3, p. 453, doi. 10.1007/s40262-025-01474-8
    By:
    • Menichelli, Danilo;
    • Pannunzio, Arianna;
    • Baldacci, Erminia;
    • Cammisotto, Vittoria;
    • Castellani, Valentina;
    • Mormile, Rosaria;
    • Palumbo, Ilaria Maria;
    • Chistolini, Antonio;
    • Violi, Francesco;
    • Harenberg, Job;
    • Pastori, Daniele;
    • Pignatelli, Pasquale
    Publication type:
    Article
    9
    10
    11